Back

Treating the sarcomere, respecting the geometry: mitral valve determinants of response to mavacamten in obstructive hypertrophic cardiomyopathy

European Heart Journal - Cardiovascular Imaging

13 July 2026
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY IMAGING Echocardiography VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease

Contributors

Bogdan A Popescu
Bogdan A Popescu

Author

Institute of Cardiovascular Diseases Prof. C.C. Iliescu Bucharest , Romania

Bianca I Cergan
Bianca I Cergan

Author

Monica Rosca
Monica Rosca

Author

You may be interested in
thumbnail
Congress Presentation
Mitral regurgitation in obstructive hypertrophic cardiomyopathy: assessing the impact of mavacamten
13 December 2024
thumbnail
Congress Presentation
Case study 2: navigating the complex waters
30 August 2025
thumbnail
Congress Presentation
The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors
31 August 2025
thumbnail
Congress Presentation
Heterogeneous left atrial strain trajectories during mavacamten therapy in obstructive hypertrophic cardiomyopathy
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources